| Primary |
| Local Anaesthesia |
27.4% |
| Anaesthesia |
12.9% |
| Induction Of Anaesthesia |
10.0% |
| Epidural Anaesthesia |
7.4% |
| General Anaesthesia |
5.8% |
| Pain |
4.0% |
| Nerve Block |
3.9% |
| Hypertension |
3.5% |
| Musculoskeletal Pain |
3.3% |
| Maintenance Of Anaesthesia |
2.9% |
| Premedication |
2.8% |
| Infiltration Anaesthesia |
2.7% |
| Neuralgia |
2.4% |
| Caesarean Section |
2.2% |
| Analgesic Therapy |
1.8% |
| Osteoarthritis |
1.8% |
| Bronchoscopy |
1.5% |
| Back Pain |
1.3% |
| Spinal Anaesthesia |
1.3% |
| Surgery |
1.2% |
|
| Anaphylactic Shock |
16.9% |
| Shock |
15.4% |
| Inflammation |
8.2% |
| Urticaria |
6.0% |
| Overdose |
5.2% |
| Tremor |
5.2% |
| Incision Site Haemorrhage |
4.5% |
| Tachycardia |
4.5% |
| Drug Toxicity |
4.1% |
| Paraplegia |
3.7% |
| Musculoskeletal Pain |
3.4% |
| Anaphylactic Reaction |
2.6% |
| Angioedema |
2.6% |
| Arthritis Bacterial |
2.6% |
| Bronchospasm |
2.6% |
| Convulsion |
2.6% |
| Haemorrhage |
2.6% |
| Hypotension |
2.6% |
| Loss Of Consciousness |
2.2% |
| Pyrexia |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
34.2% |
| Local Anaesthesia |
8.5% |
| Drug Use For Unknown Indication |
7.3% |
| Ill-defined Disorder |
6.3% |
| Musculoskeletal Pain |
5.4% |
| Epidural Anaesthesia |
4.9% |
| Anaesthesia |
4.0% |
| Cataract |
3.2% |
| Nerve Block |
3.1% |
| General Anaesthesia |
2.7% |
| Induction Of Anaesthesia |
2.4% |
| Premedication |
2.4% |
| Infiltration Anaesthesia |
2.3% |
| Back Pain |
2.2% |
| Constipation |
1.9% |
| Pain |
1.9% |
| Hypertension |
1.9% |
| Pyrexia |
1.8% |
| Analgesic Therapy |
1.8% |
| Infection |
1.8% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
9.9% |
| Depressed Level Of Consciousness |
9.4% |
| Anaphylactic Shock |
8.5% |
| Shock |
8.5% |
| Tachycardia |
7.1% |
| Toxic Epidermal Necrolysis |
7.1% |
| Musculoskeletal Pain |
5.2% |
| Urticaria |
5.2% |
| Respiratory Arrest |
4.7% |
| Incision Site Haemorrhage |
3.8% |
| Loss Of Consciousness |
3.8% |
| Paralysis |
3.8% |
| Bacterial Infection |
3.3% |
| Angioedema |
2.8% |
| Blood Creatine Increased |
2.8% |
| Cellulitis |
2.8% |
| Convulsion |
2.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.8% |
| Sinus Bradycardia |
2.8% |
| Toxic Skin Eruption |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.6% |
| Drug Use For Unknown Indication |
13.8% |
| Pain |
11.5% |
| Prophylaxis |
9.7% |
| Fluid Replacement |
4.5% |
| Hypertension |
4.4% |
| Rheumatoid Arthritis |
4.2% |
| Sedation |
3.6% |
| Constipation |
3.6% |
| Asthma |
2.9% |
| Anaesthesia |
2.8% |
| Cancer Pain |
2.8% |
| Stomatitis |
2.8% |
| Insomnia |
2.4% |
| Infection |
2.2% |
| Nausea |
2.2% |
| Infection Prophylaxis |
2.0% |
| Pyrexia |
1.8% |
| Multiple Myeloma |
1.7% |
| Diabetes Mellitus |
1.6% |
|
| Vomiting |
14.4% |
| Weight Decreased |
10.5% |
| White Blood Cell Count Decreased |
10.5% |
| Respiratory Failure |
8.2% |
| Yellow Skin |
4.9% |
| Nausea |
4.6% |
| Pyrexia |
4.6% |
| Drug Prescribing Error |
3.6% |
| Stomatitis |
3.6% |
| Wrong Technique In Drug Usage Process |
3.6% |
| Multi-organ Failure |
3.3% |
| Sepsis |
3.3% |
| Small For Dates Baby |
3.3% |
| Somnolence |
3.3% |
| Tachycardia |
3.3% |
| Vertigo |
3.3% |
| Pneumonia |
3.0% |
| Pulmonary Embolism |
3.0% |
| Respiratory Disorder |
3.0% |
| Tumour Lysis Syndrome |
3.0% |
|
| Interacting |
| Aphthous Stomatitis |
20.0% |
| Drug Use For Unknown Indication |
20.0% |
| Mouth Ulceration |
20.0% |
| Oesophageal Ulcer |
20.0% |
| Type 2 Diabetes Mellitus |
20.0% |
|
|
